AVISTA HEALTHCARE PARTNERS, L.P. purchased 50.9% of their position (8M shares) of RVL PHARMACEUTICALS PLC on the open market
Open‑market purchase worth $12.40M — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/9/2022ACC: 0001104659-22-088025
10% Owner
Since Jan 2020
+8M
Net shares
Net buyer
$12.40M
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
8M acquired
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
+8M
Price / share
$1.55
Trade value
$12.40M
% of position
50.9%
8/8/2022
15.73M→23.73M
Total
Net shares
+8M
Net value
$12.40M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 8/8/2022 | P · Purchase | +8M | $1.55 | $12.40M | 50.9% | 15.73M | 23.73M |
| Total | +8M | $12.40M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Ordinary Shares
IndirectShares owned1.03M
Total
1.03M indirect1.03M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 1.03M | Indirect |
| Total | 1.03M | 1.03M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported